<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="38587">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02024022</url>
  </required_header>
  <id_info>
    <org_study_id>COL GASTRO 4</org_study_id>
    <nct_id>NCT02024022</nct_id>
  </id_info>
  <brief_title>A Multicenter Single-blind Comparison Between Standard and Individualized Approach in Bowel Preparation Before Colonoscopy</brief_title>
  <official_title>A Comparison of Bowel Prep Quality and Patient Satisfaction in Outpatients Undergoing Colonoscopy Preparation With Either a Standard Bowel Preparation or an Individualized Approach Using Sodium Picosulphatge/Magnesium Citrate or 4L Polyethylene Glycol Preparation Regimens</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Clinical Hospital Colentina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Clinical Hospital Colentina</source>
  <oversight_info>
    <authority>Romania: National Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to compare a standard approach to bowel preparation for colonoscopy (using
      sodium picosulphate/magnesium citrate or 4lPEG) to an individualized approach where patients
      are assigned a specific regimen of either sodium picosulphate/magnesium citrate or 4lPEG
      depending on patient-related factors. The study aims to compare patient-related outcomes
      such as comfort levels during bowel cleansing and physician-related outcomes such as bowel
      prep quality in the two study groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2014</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">September 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor)</study_design>
  <primary_outcome>
    <measure>bowel cleansing</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>bowel cleansing as assessed during colonoscopy using 2 assessment scales (Boston bowel prep scale, and a 1-4 semiquantitative scale)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>patient comfort level during bowel cleansing</measure>
    <time_frame>24 hours</time_frame>
    <safety_issue>No</safety_issue>
    <description>patient pain levels on a 0-10 visual analogue scale during the bowel cleansing process</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Bowel Cleansing Process</condition>
  <condition>Colonoscopy</condition>
  <arm_group>
    <arm_group_label>Standard approach</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients will be randomized to one of the 2 currently used bowel preparation regimens in our clinic:
4L split polyethylene glycol solution
split magnesium citrate/sodium picosulphate preparation regimen</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Individualized approach</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients will receive either the 4L split polyethylene glycol bowel prep regimen or the sodium picosulphate/magnesium citrate split prep regimen according to personal characteristics assessed using a self-administered questionnaire (including bowel habits, the preference for large-volume preparation and education level)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Standard approach</intervention_name>
    <description>bowel cleansing with either 4L PEG or sodium picosulphate/magnesium citrate</description>
    <arm_group_label>Standard approach</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Individualized approach</intervention_name>
    <arm_group_label>Individualized approach</arm_group_label>
    <other_name>4 L polyethylene glycol or sodium picosulphate / magnesium citrate</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all patients &gt; 18 years of age undergoing elective colonoscopy on an outpatient basis

        Exclusion Criteria:

          -  refusal to sign informed consent

          -  pregnancy

          -  advance kidney, liver or heart disease

          -  suspicion of malignant / benign stenosis of the digestive tract
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>theodor voiosu, MD</last_name>
    <phone>0040213180604</phone>
    <email>theodor.voiosu@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Colentina Clinical Hospital</name>
      <address>
        <city>Bucharest</city>
        <zip>020125</zip>
        <country>Romania</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>theodor voiosu, MD</last_name>
      <email>theodor.voiosu@gmail.com</email>
    </contact>
    <investigator>
      <last_name>theodor voiosu, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Institutul Regional de Gastroenterologie si Hepatologie prof. dr. Octavin Fodor</name>
      <address>
        <city>Cluj</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Marcel Tantau, Professor</last_name>
      <phone>0040264596414</phone>
    </contact>
    <investigator>
      <last_name>Marcel Tantau, Professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Spitalul CFR</name>
      <address>
        <city>Cluj</city>
        <country>Romania</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Alina Tantau, MD</last_name>
      <phone>0040264599596</phone>
    </contact>
    <investigator>
      <last_name>Alina Tantau, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Romania</country>
  </location_countries>
  <reference>
    <citation>Voiosu T, Ratiu I, Voiosu A, Iordache T, Schipor A, Baicus C, Sporea I, Voiosu R. Time for individualized colonoscopy bowel-prep regimens? A randomized controlled trial comparing sodium picosulphate and magnesium citrate versus 4-liter split-dose polyethylene glycol. J Gastrointestin Liver Dis. 2013 Jun;22(2):129-34.</citation>
    <PMID>23799210</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 11, 2014</lastchanged_date>
  <firstreceived_date>December 23, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Clinical Hospital Colentina</investigator_affiliation>
    <investigator_full_name>dr. Theodor Alexandru Voiosu</investigator_full_name>
    <investigator_title>MD, gastroenterology resident</investigator_title>
  </responsible_party>
  <keyword>colonoscopy</keyword>
  <keyword>bowel cleansing</keyword>
  <keyword>polyethylene glycol</keyword>
  <keyword>sodium picosulphate / magnesium citrate</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Citric Acid</mesh_term>
    <mesh_term>Picosulfate sodium</mesh_term>
    <mesh_term>Magnesium citrate</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
